HI
STAB

Harbour Investments’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Harbour Investments’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,381
Closed – – 3147
2022
Q3 		$0 Hold
1,381
– – ﹤0.01% 2886
2022
Q2 		$0 Buy
+1,381
New +$357 ﹤0.01% 2886
2021
Q4 		$3K Hold
1,381
– – ﹤0.01% 2364
2021
Q3 		$3K Buy
+1,381
New +$5.23K ﹤0.01% 3256

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harbour Investments's STAB Position: Q4 2022 in Review

Harbour Investments sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2022, closing a stake of 1,381 shares.

Harbour Investments first reported a position in STAB in Q3 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 29 funds tracked by Wall St. Rank hold STAB as of Q4 2022.

  • Harbour Investments reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Harbour Investments sold 1,381 Statera Biopharma, Inc. Common Stock shares in Q4 2022.
  • Harbour Investments first reported a position in Statera Biopharma, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Harbour Investments's Statera Biopharma, Inc. Common Stock position peaked at $3K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2022.

Based on Harbour Investments's 13F filing for Q4 2022, filed 16 Feb 2023.